These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 3014076)

  • 1. An overview of labetalol and adrenergic effects.
    Flamenbaum W
    J Clin Hypertens; 1985 Mar; 1(1):53-5. PubMed ID: 3014076
    [No Abstract]   [Full Text] [Related]  

  • 2. Placental and fetal hemodynamics after labetalol or pindolol in a sheep model of increased placental vascular resistance and maternal hypertension.
    Erkinaro T; Kavasmaa T; Ylikauma L; Mäkikallio K; Haapsamo M; Acharya G; Ohtonen P; Alahuhta S; Räsänen J
    Reprod Sci; 2009 Aug; 16(8):749-57. PubMed ID: 19380903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Labetalol: potent antihypertensive agent that blocks both alpha- and beta-adrenergic receptors.
    Milne BJ; Logan AG
    Can Med Assoc J; 1980 Nov; 123(10):1013-6. PubMed ID: 6256045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of hypertension with the alpha- and beta-adrenergic blockader trandat].
    Erina EV; Charyev KhE; Lediashova GA; Smolenskiĭ AV
    Ter Arkh; 1983; 55(9):43-8. PubMed ID: 6314576
    [No Abstract]   [Full Text] [Related]  

  • 5. [Exogenous adrenergic stimulation by intravenous infusions of isoproterenol and blood levels of cyclic AMP before and after beta-blocking in humans].
    Nami R; Pizzuti M; Nardi PL; D'Ascenzo G; Maioli E; Gennari C
    Boll Soc Ital Cardiol; 1980; 25(7):763-8. PubMed ID: 6115658
    [No Abstract]   [Full Text] [Related]  

  • 6. The use of labetalol for the treatment of hypertension in patients with reversible airway obstruction.
    George RB; Light RW; Hudson L; Conrad SA; Manocha KL; Burford JG
    J Clin Hypertens; 1985 Mar; 1(1):80-3. PubMed ID: 3836298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Vascular arterial effect of labetalol evaluated by measuring arterial distensibility during the exercise test].
    Siché JP; de Gaudemaris R; d'Allens H; Mallion JM
    Ann Cardiol Angeiol (Paris); 1989 Oct; 38(8):509-13. PubMed ID: 2596821
    [No Abstract]   [Full Text] [Related]  

  • 8. [Combined alpha and beta blockade with labetalol. Multicenter general practice study in hypertensive patients with concomitant coronary heart disease].
    Haehn KD; Hotan W; Moerchel J; Müller J
    Fortschr Med; 1987 Sep; 105(27):532-6. PubMed ID: 2824307
    [No Abstract]   [Full Text] [Related]  

  • 9. Intravenous labetalol in the emergency treatment of hypertension.
    Vidt DG
    J Clin Hypertens; 1985 Jun; 1(2):179-86. PubMed ID: 3915322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-adrenergic blockade in the treatment of essential hypertension.
    De Leeuw PW; Birkenhäger WH
    Neth J Med; 1983; 26(9):274-82. PubMed ID: 6140644
    [No Abstract]   [Full Text] [Related]  

  • 11. Low ventricular performance and high resistance in established hypertension in adults.
    Yi G; Stone S; Dao B
    J Hypertens; 1993 Nov; 11(11):1243-51. PubMed ID: 8301106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined alpha- and beta-adrenergic blockade in the treatment of hypertension. Introductory remarks: alpha- and beta-adrenergic receptors and the cardiovascular system.
    Vanhoutte PM
    J Cardiovasc Pharmacol; 1981; 3 Suppl 1():S1-13. PubMed ID: 6169954
    [No Abstract]   [Full Text] [Related]  

  • 13. Adrenergic receptors.
    Herlihy JT; Herlihy BL
    Crit Care Nurse; 1986; 6(2):16-8. PubMed ID: 3009092
    [No Abstract]   [Full Text] [Related]  

  • 14. A study of labetalol, a new alpha- and beta-adrenoceptor blocking agent, in humans.
    Vas A; Gachályi B; Káldor A
    Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):491-2. PubMed ID: 7141757
    [No Abstract]   [Full Text] [Related]  

  • 15. Antihypertensive actions of an isomer of labetalol and other vasodilator-beta-adrenoceptor blockers.
    Baum T; Sybertz EJ
    Fed Proc; 1983 Feb; 42(2):176-81. PubMed ID: 6130003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential haemodynamic effects of labetalol at rest and during exercise in essential hypertension.
    Svendsen TL; Rasmussen S; Hartling OJ; Nielsen PE; Trap-Jensen J
    Postgrad Med J; 1980; 56 Suppl 2():21-6. PubMed ID: 7433338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Adrenergic receptors in physiopathology and clinical medicine: current role and research prospectives].
    Campanacci L; Carretta R; Fabris B
    G Clin Med; 1986 Aug; 67(4):195-205. PubMed ID: 3040503
    [No Abstract]   [Full Text] [Related]  

  • 18. [Adrenoceptor dysfunction in essential hypertension].
    Kohara K; Mikami H; Ogihara T
    Nihon Rinsho; 1992 Apr; 50 Suppl():277-82. PubMed ID: 1321919
    [No Abstract]   [Full Text] [Related]  

  • 19. Acute effect of labetalol on hypertensive brachial artery.
    Pithois-Merli IM; Cournot AX; Georges DR; Pappo M; Safar ME
    J Clin Hypertens; 1987 Dec; 3(4):479-86. PubMed ID: 3453384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sympathetic activity and presynaptic adrenoceptor function in patients with longstanding essential hypertension.
    Chang PC; Kriek E; van Brummelen P
    J Hypertens; 1994 Feb; 12(2):179-90. PubMed ID: 8021470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.